CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered

CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered

Source: 
Forbes
snippet: 

CVS Caremark changed its formulary to favor Hyrimoz. But this may not be what policymakers had in mind ten years ago when they first thought about biosimilar competition.